Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma

dc.date.accessioned2019-02-06T14:51:17Z
dc.date.available2019-02-06T14:51:17Z
dc.date.created2019-02-06T14:51:17Z
dc.date.issued2016
dc.identifierhttps://hdl.handle.net/20.500.12866/5195
dc.identifierhttps://doi.org/10.1001/jamadermatol.2016.1310
dc.description.abstractEumycetoma is a chronic granulomatous fungal disease of the subcutaneous tissues characterized by large tumorous masses and the production either black or white grains. As a result of the use of molecular diagnostic techniques, previously unrecognized causative agents of eumycetoma have been discovered. We report the first case to our knowledge of eumycetoma caused by Phaeoacremonium sphinctrophorum...
dc.languageeng
dc.publisherAmerican Medical Association
dc.relationJAMA Dermatology
dc.relation2168-6084
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAdult
dc.subjectAntifungal Agents/therapeutic use
dc.subjectAscomycota/isolation & purification
dc.subjectBiopsy, Needle
dc.subjectFollow-Up Studies
dc.subjectFoot Dermatoses/drug therapy/microbiology/pathology
dc.subjectHumans
dc.subjectImmunohistochemistry
dc.subjectItraconazole/therapeutic use
dc.subjectMale
dc.subjectMycetoma/diagnosis/drug therapy/pathology
dc.subjectSeverity of Illness Index
dc.subjectTreatment Outcome
dc.titlePhaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución